Table 2.
Results of Neurocognitive Assessment by Using CANTAB for Ultra-High Risk for Schizophrenia (UHR) vs. Familial High-Risk for Schizophrenia (FHR) Individuals
Test | Variables |
UHR (N = 40)
Mean ± SD |
FHR (N = 34)
Mean ± SD |
t | P-Value |
---|---|---|---|---|---|
Spatial Span | |||||
Span length | 4.9 ± 1.12 | 6.03 ± 1.29 | 4.018 | < 0.001 | |
Mean time to first response | 3181.35 ± 637.41 | 3099.91 ± 529.33 | -0.591 | 0.556 | |
Mean time to last response | 4001.42 ± 728.21 | 3982.55 ± 630.05 | -0.118 | 0.906 | |
Total errors | 13.18 ± 5.47 | 13.62 ± 5.71 | 0.340 | 0.735 | |
Total usage errors | 1.85 ± 1.64 | 1.82 ± 1.54 | -0.071 | 0.944 | |
Stocking of Cambridge |
|||||
Mean initial thinking time: 2-moves |
1344.24 ± 1287.44 | 1032.98 ± 1036.67 | -1.121 | 0.266 | |
Mean initial thinking time: 3-moves |
3203.03 ± 2563.85 | 2022.17 ± 1600.50 | -2.370 | 0.021 | |
Mean initial thinking time: 4-moves |
2879.36 ± 1831.34 | 193.20 ± 1232.34 | -2.592 | 0.012 | |
Mean initial thinking time: 5-moves |
2881.67 ± 2178.36 | 2824.22 ± 3085.24 | -0.092 | 0.927 | |
Mean subsequent thinking time: 2-moves |
468.21 ± 640.37 | 86.39 ± 232.93 | -3.431 | 0.001 | |
Mean subsequent thinking time: 3-moves |
484.58 ± 805.46 | 93.07 ± 339.96 | -2.736 | 0.009 | |
Mean subsequent thinking time: 4-moves |
1516.90 ± 1616.06 | 598.04 ± 682.67 | -3.232 | 0.002 | |
Mean subsequent thinking time: 5-moves |
1475.33 ± 1634.57 | 541.25 ± 1213.51 | -2.771 | 0.007 | |
Problems solved in minimum moves |
6.02 ± 2.21 | 7.11 ± 1.17 | 2.706 | 0.009 | |
Intra-Extra Dimension (IED) |
|||||
Completed stage errors | 9.700 ± 5.482 | 9.176 ± 6.233 | -0.489 | 0.626 | |
Completed stage trials | 63.925 ± 20.520 | 66.205 ± 7.441 | -0.654 | 0.516 | |
Stages completed | 8.200 ± 2.344 | 8.882 ± 0.447 | 1.797 | 0.079 | |
Total errors | 10.800 ± 6.131 | 10.911 ± 7.166 | 0.072 | 0.943 | |
Total trials | 66.475 ± 19.144 | 69.147 ± 10.719 | 0.723 | 0.472 |
Abbreviations: CANTAB: The Cambridge Neuropsychological Test Automated Battery; UHR: Ultra-High Risk for Schizophrenia; FHR: Familial High-Risk for Schizophrenia.